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Dear Editor,
In  the last two decades, the scientiﬁc community has recog-
nized  the Microsporidia importance and associated it with
serious  infections in immunocompromised patients.1 Since
its  discovery in 1857, there was  controversies in its phyloge-
netic  classiﬁcation, being recently classiﬁed as fungi.1,2 There
have  been described 150 genera and over 1300 species. Eight
genera  are described in human hosts: Enterocytozoon, Encephal-
itozzon,  Pleistophora, Trachipleistophora, Vittaforma, Brachiola,
Nosema,  and Microsporidium. Fourteen species are associated
with  human diseases, including Enterocytozoon bieneusi and
Encephalitozoon intestinalis. Microsporidia causes systemic and
non-systemic  diseases, with wide spectrum of clinical mani-
festation,  principally chronic diarrhea.3
As little is known about microsporidia and its importance
as  infectious agent in immunocompromised patients, we con-
ducted a retrospective study in 347 stool samples analyzed for
the presence of microsporidiosis to describe the associated
underlying diseases. The data were registered in the Para-
sitology  Laboratory of UNICAMP (2011–2012). All patients for
whom  there was  a medical request to exam the stools for the
presence  of microsporidia were  included. Patients’ underlying
disease  was  recorded.Out  of the 347 [210 (60.52%) males] fecal samples analyzed,
140  (40.34%) were  positive for microsporidia. The majority of
the  positive samples came from male patients [94 (67.14%)].
Table 1 – Microsporidia identiﬁcation related to clinical status.
Groups n Positive cases % (related to grou
HIV+/AIDS 120 51 42.50% 
Transplantion 100 42 42% 
Gastric diseases 28 9 32.14% 
Renal diseases 26 11 42.30% 
Liver diseases 25 6 24.0% 
Neoplasia 10 3 30.0% 
Lupus 8 4 20.0% 
Tuberculosis 6 5 83.33% 
Cystic ﬁbrosis 3 0 0% 
Others 21 9 42.85% 
Total 347 140 – 
n, number of patients; %, percentage; OR, odds ratio; CI, conﬁdence interveference  center
Table 1 shows the underlying diseases of patients found
with  microsporidia in their feces. The positivity rates were
75%  (75/100), 22% (22/100), and 3% (3/100) among those who
underwent  bone marrow, kidney and liver transplantation,
respectively.
The underlying diseases of the positive cases were  diar-
rhea  (eight), Crohn’s disease (one), leukemia (one), lymphoma
(two),  chronic renal failure (two), nephritic syndrome (two),
end-stage  renal disease (ﬁve), cirrhosis (six), pulmonary dis-
ease  (two), immunodeﬁciency (1), and none (5).
Microsporidiosis is a cosmopolitan disease whose preva-
lence  has wide variability depending on the geographic region,
population  studied and diagnostic methods.4 Immunocom-
promised patients are more  affected by serious microsporidio-
sis,  especially HIV-patients. In the early ‘80s, before the AIDS
epidemic,  microsporidiosis was  rarely described in humans.
Since  1990, the prevalence of HIV-associated microsporidia
infection has been reported to range from 1.5 to 50%.3 Trans-
planted  patients are another risk group for microsporidiosis.5
The wide spectrum of clinical manifestations depends
on  the species, site of infection and host immunity.4 Gas-
trointestinal microsporidiosis is predominantly observed in
HIV-patients, especially with advanced immunosuppression.1ps) % (related to all patients) OR (95% CI)
14.70% 1.146 (0.729–1.797)
12.02% 1.101 (0.684–1.765)
2.63% 0.681 (0.285–1.536)
3.19% 1.091 (0.472–2.465)
1.73% 0.444 (0.158–1.109)
0.87% 0.444 (0.158–1.109)
1.15% 0.6265 (0.129–2.428)
1.45% 1.491 (0.331–6.713)
0% –
2.60% 1.116 (0.441–2.751)
40.34%
al.
immunocompetent, as well as in immunocompromised
patients. The search for microsporidia in fecal samples should
be  performed in immunocompromised patients, even without
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ymptoms, not only due to the risk of overt symptoms, but also
ecause  of the signiﬁcant transmission risk.1
In conclusion, high positivity for microsporidiosis was
bserved among HIV-infected patients and transplant recip-
ents,  highlighting the importance of early diagnosis and
mplementation of measures for disease prevention.
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